|
|
Gene Symbol |
TNF |
|
Aliases |
DIF, TNF-alpha, TNFA, TNFSF2, TNLG1F |
|
Entrez Gene ID |
|
|
Gene Name |
Tumor necrosis factor |
|
Chromosomal Location |
6p21.33 |
|
HGNC ID |
|
|
Summary |
This gene encodes a multifunctional proinflammatory cytokine that belongs to the tumor necrosis factor (TNF) superfamily. This cytokine is mainly secreted by macrophages. It can bind to, and thus functions through its receptors TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. This cytokine is involved in the regulation of a wide spectrum of biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation. This cytokine has been implicated in a variety of diseases, including autoimmune diseases, insulin resistance, and cancer. Knockout studies in mice also suggested the neuroprotective function of this cytokine. [provided by RefSeq, Jul 2008]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0000122 |
Biological process |
Negative regulation of transcription by RNA polymerase II |
IDA |
1618860, 15345745 |
GO:0000165 |
Biological process |
MAPK cascade |
IMP |
21147091 |
GO:0000185 |
Biological process |
Activation of MAPKKK activity |
IDA |
15310755 |
GO:0000187 |
Biological process |
Activation of MAPK activity |
IDA |
10748004 |
GO:0001774 |
Biological process |
Microglial cell activation |
NAS |
26753638 |
GO:0001819 |
Biological process |
Positive regulation of cytokine production |
IDA |
17922812 |
GO:0001934 |
Biological process |
Positive regulation of protein phosphorylation |
IDA |
10748004, 16723520, 17389591 |
GO:0002439 |
Biological process |
Chronic inflammatory response to antigenic stimulus |
IMP |
14512626 |
GO:0002740 |
Biological process |
Negative regulation of cytokine secretion involved in immune response |
IDA |
10443688 |
GO:0006919 |
Biological process |
Activation of cysteine-type endopeptidase activity involved in apoptotic process |
IDA |
16723520 |
GO:0006954 |
Biological process |
Inflammatory response |
IDA |
10748004, 21147091, 22267480 |
GO:0008625 |
Biological process |
Extrinsic apoptotic signaling pathway via death domain receptors |
IBA |
21873635 |
GO:0008625 |
Biological process |
Extrinsic apoptotic signaling pathway via death domain receptors |
IDA |
10521396, 18202225, 18676776 |
GO:0008625 |
Biological process |
Extrinsic apoptotic signaling pathway via death domain receptors |
NAS |
21319131 |
GO:0009615 |
Biological process |
Response to virus |
IDA |
10490959 |
GO:0009651 |
Biological process |
Response to salt stress |
TAS |
18355445 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
IDA |
11085990, 21559518, 22267480, 23817958, 24998411, 26371161 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
IGI |
24299952 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
IMP |
16203728, 23892569 |
GO:0010629 |
Biological process |
Negative regulation of gene expression |
IDA |
15345745, 22267480, 26371161 |
GO:0010629 |
Biological process |
Negative regulation of gene expression |
IGI |
24299952 |
GO:0010888 |
Biological process |
Negative regulation of lipid storage |
NAS |
16464856 |
GO:0030730 |
Biological process |
Sequestering of triglyceride |
IDA |
19032770 |
GO:0030866 |
Biological process |
Cortical actin cytoskeleton organization |
IDA |
25816133 |
GO:0031334 |
Biological process |
Positive regulation of protein complex assembly |
IDA |
12813029 |
GO:0031663 |
Biological process |
Lipopolysaccharide-mediated signaling pathway |
IDA |
21147091 |
GO:0032715 |
Biological process |
Negative regulation of interleukin-6 production |
IDA |
10443688 |
GO:0032722 |
Biological process |
Positive regulation of chemokine production |
IDA |
10490959 |
GO:0032755 |
Biological process |
Positive regulation of interleukin-6 production |
IDA |
24299952 |
GO:0032757 |
Biological process |
Positive regulation of interleukin-8 production |
IMP |
24790089 |
GO:0032800 |
Biological process |
Receptor biosynthetic process |
IDA |
10443688 |
GO:0033138 |
Biological process |
Positive regulation of peptidyl-serine phosphorylation |
IDA |
17389591, 18440775 |
GO:0033209 |
Biological process |
Tumor necrosis factor-mediated signaling pathway |
IBA |
21873635 |
GO:0033209 |
Biological process |
Tumor necrosis factor-mediated signaling pathway |
IMP |
10748004 |
GO:0034116 |
Biological process |
Positive regulation of heterotypic cell-cell adhesion |
IDA |
10604883, 20551324 |
GO:0035509 |
Biological process |
Negative regulation of myosin-light-chain-phosphatase activity |
IDA |
25816133 |
GO:0043065 |
Biological process |
Positive regulation of apoptotic process |
IDA |
16723520, 17389591, 22173242 |
GO:0043065 |
Biological process |
Positive regulation of apoptotic process |
IMP |
9343261 |
GO:0043068 |
Biological process |
Positive regulation of programmed cell death |
IDA |
16611992 |
GO:0043122 |
Biological process |
Regulation of I-kappaB kinase/NF-kappaB signaling |
IDA |
10748004 |
GO:0043123 |
Biological process |
Positive regulation of I-kappaB kinase/NF-kappaB signaling |
IBA |
21873635 |
GO:0043123 |
Biological process |
Positive regulation of I-kappaB kinase/NF-kappaB signaling |
IDA |
15310755, 17922812 |
GO:0043123 |
Biological process |
Positive regulation of I-kappaB kinase/NF-kappaB signaling |
TAS |
29702085 |
GO:0043242 |
Biological process |
Negative regulation of protein complex disassembly |
IDA |
17389591 |
GO:0043243 |
Biological process |
Positive regulation of protein complex disassembly |
IDA |
12813029, 17389591 |
GO:0043280 |
Biological process |
Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
IDA |
11577081 |
GO:0043406 |
Biological process |
Positive regulation of MAP kinase activity |
IDA |
12813029, 17389591, 18440775 |
GO:0043491 |
Biological process |
Protein kinase B signaling |
IMP |
21147091 |
GO:0043507 |
Biological process |
Positive regulation of JUN kinase activity |
IDA |
17389591 |
GO:0045071 |
Biological process |
Negative regulation of viral genome replication |
IDA |
10490959 |
GO:0045080 |
Biological process |
Positive regulation of chemokine biosynthetic process |
IDA |
10490959 |
GO:0045416 |
Biological process |
Positive regulation of interleukin-8 biosynthetic process |
IDA |
20551324 |
GO:0045429 |
Biological process |
Positive regulation of nitric oxide biosynthetic process |
IDA |
8383325 |
GO:0045599 |
Biological process |
Negative regulation of fat cell differentiation |
NAS |
16464856 |
GO:0045672 |
Biological process |
Positive regulation of osteoclast differentiation |
IDA |
17888176 |
GO:0045732 |
Biological process |
Positive regulation of protein catabolic process |
IDA |
18632959 |
GO:0045785 |
Biological process |
Positive regulation of cell adhesion |
IMP |
23892569 |
GO:0045860 |
Biological process |
Positive regulation of protein kinase activity |
IDA |
11821416 |
GO:0045892 |
Biological process |
Negative regulation of transcription, DNA-templated |
IDA |
16895791, 17350185 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
IDA |
10748004, 14512626, 17350185 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IBA |
21873635 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IDA |
15345745, 20551324 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IGI |
16803872 |
GO:0048143 |
Biological process |
Astrocyte activation |
NAS |
26753638 |
GO:0048566 |
Biological process |
Embryonic digestive tract development |
IEP |
20875417 |
GO:0048661 |
Biological process |
Positive regulation of smooth muscle cell proliferation |
IDA |
16518841 |
GO:0050715 |
Biological process |
Positive regulation of cytokine secretion |
IDA |
10443688 |
GO:0050729 |
Biological process |
Positive regulation of inflammatory response |
TAS |
24966471 |
GO:0050766 |
Biological process |
Positive regulation of phagocytosis |
IMP |
18201371 |
GO:0050768 |
Biological process |
Negative regulation of neurogenesis |
TAS |
20018408 |
GO:0050796 |
Biological process |
Regulation of insulin secretion |
IDA |
8383325 |
GO:0050890 |
Biological process |
Cognition |
TAS |
22277195 |
GO:0050901 |
Biological process |
Leukocyte tethering or rolling |
IDA |
10820279 |
GO:0050995 |
Biological process |
Negative regulation of lipid catabolic process |
IDA |
19032770 |
GO:0051000 |
Biological process |
Positive regulation of nitric-oxide synthase activity |
IC |
29702085 |
GO:0051044 |
Biological process |
Positive regulation of membrane protein ectodomain proteolysis |
IDA |
18373975 |
GO:0051091 |
Biological process |
Positive regulation of DNA-binding transcription factor activity |
IDA |
10748004 |
GO:0051092 |
Biological process |
Positive regulation of NF-kappaB transcription factor activity |
IBA |
21873635 |
GO:0051092 |
Biological process |
Positive regulation of NF-kappaB transcription factor activity |
IDA |
10383454, 11374864, 11821416, 15790681, 16280327, 16611992, 20551324, 25193116 |
GO:0051092 |
Biological process |
Positive regulation of NF-kappaB transcription factor activity |
IMP |
24790089 |
GO:0051222 |
Biological process |
Positive regulation of protein transport |
IDA |
15310755 |
GO:0051384 |
Biological process |
Response to glucocorticoid |
IDA |
10443688 |
GO:0051966 |
Biological process |
Regulation of synaptic transmission, glutamatergic |
TAS |
22277195 |
GO:0060252 |
Biological process |
Positive regulation of glial cell proliferation |
IDA |
2104886 |
GO:0060252 |
Biological process |
Positive regulation of glial cell proliferation |
IGI |
1752215 |
GO:0060557 |
Biological process |
Positive regulation of vitamin D biosynthetic process |
IDA |
1690216 |
GO:0060559 |
Biological process |
Positive regulation of calcidiol 1-monooxygenase activity |
IDA |
1690216 |
GO:0061048 |
Biological process |
Negative regulation of branching involved in lung morphogenesis |
IDA |
17350185 |
GO:0070374 |
Biological process |
Positive regulation of ERK1 and ERK2 cascade |
NAS |
18606301 |
GO:0070886 |
Biological process |
Positive regulation of calcineurin-NFAT signaling cascade |
IDA |
16803872 |
GO:0071316 |
Biological process |
Cellular response to nicotine |
IDA |
18676776 |
GO:0071407 |
Biological process |
Cellular response to organic cyclic compound |
IDA |
21147091 |
GO:0071677 |
Biological process |
Positive regulation of mononuclear cell migration |
NAS |
21319131 |
GO:0071803 |
Biological process |
Positive regulation of podosome assembly |
IDA |
15220135 |
GO:0072659 |
Biological process |
Protein localization to plasma membrane |
IDA |
25816133 |
GO:0097191 |
Biological process |
Extrinsic apoptotic signaling pathway |
IDA |
11577081, 16611992 |
GO:0097527 |
Biological process |
Necroptotic signaling pathway |
IDA |
11101870, 22265413, 22265414, 22817896 |
GO:0150078 |
Biological process |
Positive regulation of neuroinflammatory response |
TAS |
22277195, 26753638 |
GO:1901224 |
Biological process |
Positive regulation of NIK/NF-kappaB signaling |
IDA |
17922812, 20041225 |
GO:1901671 |
Biological process |
Positive regulation of superoxide dismutase activity |
IDA |
22836756 |
GO:1903140 |
Biological process |
Regulation of establishment of endothelial barrier |
IDA |
25816133 |
GO:1903347 |
Biological process |
Negative regulation of bicellular tight junction assembly |
IDA |
25816133 |
GO:1903978 |
Biological process |
Regulation of microglial cell activation |
TAS |
22277195 |
GO:1904996 |
Biological process |
Positive regulation of leukocyte adhesion to vascular endothelial cell |
IDA |
26371161 |
GO:1904999 |
Biological process |
Positive regulation of leukocyte adhesion to arterial endothelial cell |
IDA |
22267480 |
GO:2000010 |
Biological process |
Positive regulation of protein localization to cell surface |
IDA |
19366699 |
GO:2000334 |
Biological process |
Positive regulation of blood microparticle formation |
IDA |
24998411 |
GO:2000343 |
Biological process |
Positive regulation of chemokine (C-X-C motif) ligand 2 production |
IDA |
20551324 |
GO:2000351 |
Biological process |
Regulation of endothelial cell apoptotic process |
IMP |
10843670 |
GO:2000778 |
Biological process |
Positive regulation of interleukin-6 secretion |
TAS |
29702085 |
GO:2001240 |
Biological process |
Negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
IDA |
10666185, 10748004 |
GO:0005615 |
Cellular component |
Extracellular space |
IBA |
21873635 |
GO:0005615 |
Cellular component |
Extracellular space |
IDA |
3932069, 10443688, 12594207, 18355445, 21323571 |
GO:0005887 |
Cellular component |
Integral component of plasma membrane |
IDA |
18355445 |
GO:0009986 |
Cellular component |
Cell surface |
IBA |
21873635 |
GO:0009986 |
Cellular component |
Cell surface |
IDA |
18355445 |
GO:0045121 |
Cellular component |
Membrane raft |
IDA |
17010968 |
GO:0002020 |
Molecular function |
Protease binding |
IPI |
12777399 |
GO:0005125 |
Molecular function |
Cytokine activity |
IBA |
21873635 |
GO:0005125 |
Molecular function |
Cytokine activity |
IDA |
10748004 |
GO:0005164 |
Molecular function |
Tumor necrosis factor receptor binding |
IBA |
21873635 |
GO:0005164 |
Molecular function |
Tumor necrosis factor receptor binding |
IDA |
14512626 |
GO:0005164 |
Molecular function |
Tumor necrosis factor receptor binding |
IPI |
9435233 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
2848815, 11878931, 12887920, 14743216, 17681535, 19838188, 20080539, 20103630, 21784977, 22028622, 23032186, 23104095, 23955153, 24070898, 25241761, 25911380, 26649818, 30561431 |
GO:0042802 |
Molecular function |
Identical protein binding |
IDA |
14512626 |
GO:0042802 |
Molecular function |
Identical protein binding |
IPI |
2922050, 19838188, 23815148 |
GO:0044212 |
Molecular function |
Transcription regulatory region DNA binding |
IDA |
17350185 |
|
Protein Information |
|
Protein Name |
Tumor necrosis factor, APC1 protein, TNF, macrophage-derived, TNF, monocyte-derived, TNF-a, cachectin, tumor necrosis factor ligand 1F, tumor necrosis factor ligand superfamily member 2, tumor necrosis factor-alpha |
|
Function |
|
|
|
|
|
UniProt |
|
|
PDB |
4Y6O, 3L9J, 1A8M, 1TNF, 2AZ5, 2E7A, 2TUN, 2ZJC, 2ZPX, 3ALQ, 3IT8, 3WD5, 4G3Y, 4TSV, 4TWT, 5M2I, 5M2J, 5M2M, 5MU8, 5TSW, 5UUI, 5WUX, 5YOY |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000325120 |
P06401 |
P06401 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Blood Disorders |
Fanconi Anemia |
|
Anemia |
|
Cardiovascular Diseases |
Acute Coronary Syndrome |
|
Heart Failure |
|
Myocardial Infarction |
|
Myocardial Failure |
|
Hypertensive disease |
|
Carditis |
|
Cardiac Arrest |
|
Diabetic Cardiomyopathies |
|
Myocardial Diseases |
|
Myocarditis |
|
Myocardial Stunning |
|
Myocardial Ischemia |
|
Cardiomyopathy |
|
Vascular Diseases |
|
Coronary Restenosis |
|
Angina pectoris |
|
Atherosclerosis |
|
Hibernating Myocardium |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Sickle Cell Anemia |
|
Wilson Disease |
|
Digestive System Diseases |
Fatty Liver |
|
Liver Diseases |
|
Colitis |
|
Hepatitis, Alcoholic |
|
Crohn Disease |
|
Cholestasis |
|
Oral submucosal fibrosis |
|
Inflammatory Bowel Diseases |
|
Hepatitis |
|
Liver Cirrhosis |
|
Liver Failure |
|
Gastric ulcer |
|
Enteritis |
|
Endocrine System Diseases |
Diabetes Mellitus |
|
Ketosis-prone diabetes |
|
Brittle diabetes |
|
PCOS |
|
Eye Diseases |
Retinal Diseases |
|
Immune System Diseases |
Rheumatoid Arthritis |
|
HIV Wasting Syndrome |
|
Urticaria |
|
AIDS |
|
Autoimmune Diabetes |
|
Graves Disease |
|
Dermatitis |
|
Musculoskeletal Diseases |
Polymyositis |
|
Arthritis |
|
Osteoporosis |
|
Arthritis, Psoriatic |
|
Neoplasms |
Breast Cancer |
|
Carcinoma |
|
Colonic Neoplasms |
|
Sarcoma |
|
Stomach Cancer |
|
Adenocarcinoma |
|
Gastric Cancer |
|
Lung Cancer |
|
Soft Tissue Neoplasms |
|
Pancreatic Neoplasm |
|
Glioma |
|
Colorectal Cancer |
|
Bladder Cancer |
|
Thyroid Cancer |
|
Liver Cancer |
|
Fibromatosis |
|
Cribriform Carcinoma |
|
Nervous System Diseases |
Compression of spinal cord |
|
Lateral Sclerosis |
|
Status Epilepticus |
|
Stroke |
|
Myopathy |
|
Arsenic Encephalopathy |
|
Neuralgia |
|
Cerebral Edema |
|
Trigeminal neuralgia |
|
Parkinson Disease |
|
Cerebral Ischemia |
|
Luft Disease |
|
Petit mal status |
|
Nutritional and Metabolic Diseases |
Obesity |
|
Hypoglycemia |
|
Milk-Alkali Syndrome |
|
Hyperhomocysteinemia |
|
Liver Failure |
|
Hepatic Encephalopathy |
|
Hemochromatosis |
|
Hypercalcemia |
|
Gluocose Intolerance |
|
Psychiatric/Brain disorders |
Mental Depression |
22580182, 25315113, 25151093, 25903726, 24094876, 24620999, 22683211, 23608119, 20351714, 22683764, 23064081 |
Bipolar Disorder |
|
Schizophrenia |
|
Senile Dementia |
|
Anxiety Disorders |
|
Mood Disorders |
|
Alzheimer Disease |
|
Obstructive Sleep Apnea |
26125882, 25411969, 29871194, 26201496, 26284518, 25222485, 31013606, 25192323, 25944984, 20846669, 19218687, 17129465, 23692992, 16246965, 24755071, 18448490 |
Renal Disorder |
Kidney Insufficiency |
|
Glomerulonephritis |
|
Nephritis |
|
Kidney Failure |
|
Hemolytic-Uremic Syndrome |
|
Reproductive disorders |
Pregnancy Complications, Cardiovascular |
|
Preeclampsia |
31154903, 28947613, 28115513, 31010153, 25667213, 29938347, 26053021, 23790133, 22182686, 22440523, 30007972 |
Respiratory Tract Diseases |
Asthma |
|
Emphysema |
|
Pleural effusion |
|
Pneumonia |
|
Pleuritis |
|
Pulmonary Fibrosis |
|
Airway Obstruction |
|
Beryllium Disease |
|
Pulmonary Emphysema |
|
Pulmonary asbestosis |
|
Bronchiectasis |
|
Chronic Obstructive Pulmonary Disease |
|
Pulmonary Edema |
|
Chronic Lung Injury |
|
Anthracosis |
|
Skin and Connective Tissue Diseases |
Leishmaniasis |
|
Dermatomyositis |
|
Scleroderma |
|
Morphea |
|
Psoriasis |
|
Pustulosis |
|
Dermatitis |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
Asymmetric dimethylarginine (ADMA), apelin |
Cardiovascular disease (CVD), including insulin resistance, type 2 diabetes mellitus, obesity, hypertension,hyperandrogenism and dyslipidemia |
|
|
Related
|
|
ADMA and TNF were positively correlated with total testosterone and free androgen index, whereas apelin was negatively correlated with these parameters. These findings may indicate that non-obese women with PCOS are at an increased risk for CVD, which is further aggravated by hyperandrogenism. |
|
|
Adipose tissue macrophage (ATM) infiltration |
|
NIH criteria |
Related
|
|
Women with PCOS had an increase in CD11c expression, CLS density, 5 expression, borderline increase in TNF expression , and a decrease in adiponectin expression in gluteal adipose tissue. |
|
|
|
-1031(T/C) polymorphism of TNF-alpha |
Rotterdam criteria |
Related
|
Korean population-217 PCOS patients and 144 controls |
The study concludes that the -1031(T/C) polymorphism of TNF-alpha gene is associated with PCOS in a Korean population. |
|
IL-6 |
|
|
|
Related
|
|
Patients with PCOS showed significantly higher serum CRP, lymphocytes, monocytes, eosinophilic granulocytes, as well as higher triglycerides (TG), TNF and IL-6 |
|
IL-6, monocyte chemoattractant protein-1 |
Low-grade chronic inflammation |
|
NIH criteria |
Related
|
|
The net change in adiponectin secretion in response to IL-6, monocyte chemoattractant protein-1, and TNF-alpha differed between PCOS (decreasing) and control (increasing) adipocytes, although the difference reached significance only for TNF-alpha |
|
IL-6 |
Obesity |
|
|
Related
|
|
Tumor necrosis factor-alpha and interleukin-6 participate in the pathogenesis of PCO syndrome through very complex mechanisms, but further study are necessary to explain them more precisely. |
|
Serum adiponectin |
Insulin resistance |
|
|
Related
|
|
TNF-alpha levels in PCOS group was higher than controls |
|
|
Insulin resistance and hyperandrogenism |
(TNF)-alpha release from mononuclear cells |
|
Related
|
|
MNC-derived TNFalpha release may contribute to insulin resistance and hyperandrogenism, particularly when the combination of PCOS and increased adiposity is present |
|
|
|
|
|
Related
|
|
TNF-alpha may have a role in ovarian function. Derangement in follicular development, luteal function and atresia results in a change of circulating TNF-alpha levels |
|
|
Hyperinsulinaemia |
|
|
Related
|
|
The decrease in TNF-alpha concentrations during oGTT and the inverse correlation between endogenous hyperinsulinaemia and serum TNF-alpha concentrations suggested an anti-inflammatory effect of moderately-high insulin concentrations |
|
|
PCOS |
G1.697A (F5), G20.210A (Prothrombin) |
|
Related
|
1 PCOS |
This study describes the association of pseudotumor cerebri, optic nerve demyelination, PCOS, other endocrinologic abnormalities, and thrombophilia due to a factor V and prothrombin mutation |
|
IL-6,stimulated production of IFN-gamma, IL-2, IL-4, IL-5, and IL-10, leukocyte numbers and hsCRP |
Cardiovascular risk,obesity and inflammation |
|
|
Related
|
|
This data confirm that obesity plays a pivotal role in inflammatory processes relevant to cardiovascular risk in women with PCOS |
|
Adiponectin,IL-6 |
|
|
|
Related
|
|
The higher levels of leptin and TNF-alpha, the lower level of adiponectin in obese PCOS and the higher level of TNF-alpha and IL-6 in non-obese PCOS suggested different adipocytokines play different roles of insulin resistance in PCOS |
|
CRP,homocysteine,PAI-1,Lp(a),VEGF,IL-6,ADMA,endothelin-1 (ET-1) and fibrinogen |
Cardiovascular disease |
|
NIH criteria, Rotterdam criteria |
Related
|
|
Women with PCOS have increased serum concentrations of CVD risk markers compared with controls. |
|
CD11c,leptin |
Inflammation and insulin resistance |
|
|
Related
|
|
CD11c mRNA abundance made a stronger contribution to models predicting sTNF in which existing proinflammatory properties might significantly contribute to the pathogenesis of IR in PCOS women |
|
|
PCOS |
|
Rotterdam criteria |
Related
|
45 women with PCOS, 45 controls |
Thrombin generation is faster in young and overweight women with PCOS |
|
|
|
|